| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |